This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Beltinger C and Debatin KM, 2001, Murine models for experimental therapy of pediatric solid tumors with poor prognosis. Int J Cancer. 92: 313–318.
Biedler JL, Helson L and Spengler BA, 1973, Morphology and growth, tumorigenicity, and cytogenetics of human neuroblastoma cells in continuous culture. Cancer Res. 33: 2643–2652.
Burchill SA, 2003, Ewing’s sarcoma: diagnostic, prognostic, and therapeutic implications of molecular abnormalities. J Clin Pathol. 56: 96–102.
Chansky HA, Hu M, Hickstein DD and Yang L, 2001, Oncogenic TLS/ERG and EWS/Fli-1 fusion proteins inhibit RNA splicing mediated by YB-1 protein. Cancer Res. 61: 3586–3590.
Colmers WF and Wahlestedt C, 1993, The Biology of Neuropeptide and Related Peptides, p. xvi, 564. Totowa, NJ, Humana Press.
de Alava E and Gerald WL, 2000, Molecular biology of the Ewing’s sarcoma/primitive neuroectodermal tumor family. J Clin Oncol. 18: 204–213.
Ekstrand AJ, Cao R, Bjorndahl M, Nystrom S, Jonsson-Rylander AC, Hassani H, Hallberg B, NordlanderMand Cao Y, 2003, Deletion of neuropeptide Y (NPY) 2 receptor in mice results in blockage of NPY-induced angiogenesis and delayed wound healing. Proc Natl Acad Sci USA. 100: 6033–6038.
Fabry M, Langer M, Rothen-Rutishauser B, Wunderli-Allenspach H, Hocker H and Beck-Sickinger AG, 2000, Monitoring of the internalization of neuropeptide Y on neuroblastoma cell line SK-N-MC. Eur J Biochem. 267: 5631–5637.
Gerald C, Walker MW, Criscione L, Gustafson EL, Batzl-Hartmann C, Smith KE, Vaysse P, Durkin MM, Laz TM, Linemeyer DL, Schaffhauser AO, Whitebread S, Hofbauer KG, Taber RI, Branchek TA and Weinshank RL, 1996, A receptor subtype involved in neuropeptide-Y-induced food intake. Nature. 382: 168–171.
Ghersi G, Chen W, Lee EW and Zukowska Z, 2001, Critical role of dipeptidyl peptidase IV in neuropeptide Y-mediated endothelial cell migration in response to wounding. Peptides. 22: 453–458.
Langer M, Kratz F, Rothen-Rutishauser B, Wunderli-Allenspach H and Beck-Sickinger AG, 2001, Novel peptide conjugates for tumor-specific chemotherapy. J Med Chem. 44: 1341–1348.
Grundemar L and B SR, 1997, Neuropeptide Y and Drug Development. San Diego, London, Academic Press.
Hansel DE, Eipper BA and Ronnett GV, 2001, Neuropeptide Y functions as a neuroproliferative factor. Nature. 410: 940–944.
Kitlinska J, Abe K, Kuo L, Pons J, Yu M, Li L, Tilan J, Everhart L, Lee EW, Zukowska Z and Toretsky JA, 2005, Differential effects of neuropeptide Y on the growth and vascularization of neural crest-derived tumors. Cancer Res. 65: 1719–1728.
Koulu M, Movafagh S, Tuohimaa J, Jaakkola U, Kallio J, Pesonen U, Geng Y, Karvonen MK, Vainio-Jylha E, Pollonen M, Kaipio-Salmi K, Seppala H, Lee EW, Higgins RD and Zukowska Z, 2004, Neuropeptide Y and Y2-receptor are involved in development of diabetic retinopathy and retinal neovascularization. Ann Med. 36: 232–240.
Kovar H, 2003, Ewing tumor biology: perspectives for innovative treatment approaches. Adv Exp Med Biol. 532: 27–37.
Larhammar D, Blomqvist AG, Yee F, Jazin E, Yoo H and Wahlestedt C, 1992, Cloning and functional expression of a human neuropeptide Y/peptide YY receptor of the Y1 type. J Biol Chem. 267: 10935–10938.
Lee EW, Michalkiewicz M, Kitlinska J, Kalezic I, Switalska H, Yoo P, Sangkharat A, Ji H, Li L, Michalkiewicz T, Ljubisavljevic M, Johansson H, Grant DS and Zukowska Z, 2003, Neuropeptide Y induces ischemic angiogenesis and restores function of ischemic skeletal muscles. J Clin Invest. 111: 1853–1862.
Lee EW, Grant DS, Movafagh S and Zukowska Z, 2003, Impaired angiogenesis in neuropeptide Y (NPY)-Y2 receptor knockout mice. Peptides. 24: 99–106.
Lessnick SL, Braun BS, Denny CT, and May WA, 1995, Multiple domains mediate transformation by the Ewing’s sarcoma EWS/FLI-1 fusion gene. Oncogene. 10: 423–431.
Mentlein R, 1999, Dipeptidyl-peptidase IV (CD26)-role in the inactivation of regulatory peptides. Regul Pept. 85: 9–24.
Pons J, Kitlinska J, Ji H, Lee EW and Zukowska Z, 2003, Mitogenic actions of neuropeptide Y in vascular smooth muscle cells: synergetic interactions with the beta-adrenergic system. Can J Physiol Pharmacol. 81: 177–185.
Reubi JC, Gugger M, Waser B and Schaer JC, 2001, Y(1)-mediated effect of neuropeptide Y in cancer: breast carcinomas as targets. Cancer Res. 61: 4636–4641.
Rodriguez-Galindo C, Spunt SL, and Pappo AS, 2003, Treatment of Ewing sarcoma family of tumors: current status and outlook for the future. Med Pediatr Oncol. 40: 276–287.
Rose PM, Fernandes P, Lynch JS, Frazier ST, Fisher SM, Kodukula K, Kienzle B and Seethala R, 1995, Cloning and functional expression of a cDNA encoding a human type 2 neuropeptide Y receptor. J Biol Chem. 270: 29038.
Shorter NA and Pence JC, 1997, Retinoic acid-induced regulation of neuropeptide Y receptor expression and function in the neuroepithelioma line SK-N-MC. J Pediatr Surg. 32: 721–723.
van Valen F, Winkelmann W and Jurgens H, 1992, Expression of functional Y1 receptors for neuropeptide Y in human Ewing’s sarcoma cell lines. J Cancer Res Clin Oncol. 118: 529–536.
Whang-Peng J, Triche TJ, Knutsen T, Miser J, Kao-Shan S, Tsai S and Israel MA, 1986, Cytogenetic characterization of selected small round cell tumors of childhood. Cancer Genet Cytogenet. 21: 185–208.
Zukowska-Grojec Z and Wahlestedt C, 1993, Origin and actions of neuropeptide Y in the cardiovascular system. In: Colmers WF and Wahlestedt C (eds.), The biology of neuropeptide Y and related peptides, pp. 315–388. Totowa, NJ, Humana Press.
Zukowska-Grojec Z, Pruszczyk P, Colton C, Yao J, Shen GH, Myers AK and Wahlestedt C, 1993, Mitogenic effect of neuropeptide Y in rat vascular smooth muscle cells. Peptides. 14: 263–268.
Zukowska-Grojec Z, Karwatowska-Prokopczuk E, Fisher TA and Ji H, 1998, Mechanisms of vascular growth-promoting effects of neuropeptide Y: role of its inducible receptors. Regul Pept. 75–76: 231–238.
Zukowska-Grojec Z, Karwatowska-Prokopczuk E, Rose W, Rone J, Movafagh S, Ji H, Yeh Y, Chen WT, Kleinman HK, Grouzmann E and Grant DS, 1998a, Neuropeptide Y: a novel angiogenic factor from the sympathetic nerves and endothelium. Circ Res. 83: 187–195.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2006 Springer Science+Business Media, Inc.
About this paper
Cite this paper
Kitlinska, J. et al. (2006). Role of Neuropeptide Y and Dipeptidyl Peptidase IV in Regulation of Ewing’s Sarcoma Growth. In: Lendeckel, U., Reinhold, D., Bank, U. (eds) Dipeptidyl Aminopeptidases. Advances in Experimental Medicine and Biology, vol 575. Springer, Boston, MA . https://doi.org/10.1007/0-387-32824-6_24
Download citation
DOI: https://doi.org/10.1007/0-387-32824-6_24
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-387-29058-4
Online ISBN: 978-0-387-32824-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)